Varuna Biocell Private Limited - Due diligence report

A 360° intelligence report on Varuna Biocell Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

1999-06-28 Varanasi, Uttar Pradesh Active Unlisted Active Compliant
Share
VB Varuna Biocell Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Varuna Biocell Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Varuna Biocell Private Limited is assessed as Low Risk with a Trust Score of 88/100. Varuna Biocell Private Limited is an active private limited indian non-government company incorporated in 1999, operating in the Chemicals and Materials sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 23 Jul 2026 from the latest processed filings. Varuna Biocell Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 3 satisfied (2.10 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Biotechnology Industry Research Assistance Council1 48.0 cr
Department Of Biotechnology1 48.0 cr
State Bank Of India1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 45/100
NameDIN / PANDesignationAppointedTenureDIN status
SADHANA PANDEY 01234567 Director 01/04/2018 6 yrs Approved
AKSHAYA PANDEY 01234567 Director 01/04/2018 6 yrs Approved
PALLAVI RANIGA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • PALLAVI RANIGA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 80
Growth signals & trust indicators
Operating for 27+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Profit declined two years in a row.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence90/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment92/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view75/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
18 Sep 2025
Charge satisfied
Biotechnology Industry Research Assistance Council
31 Mar 2025
Latest balance sheet
Filed with ROC
23 Sep 2024
Director appointed
AKSHAYA PANDEY (Director)
31 Mar 2024
Director ceased
VIDYA BHUSHAN SHARMA
15 Jul 2022
Charge satisfied
Department Of Biotechnology
17 Nov 2020
Director ceased
MANISH RANIGA
03 Aug 2019
Charge satisfied
State Bank Of India
07 Feb 2019
Director ceased
PRABHAT SHANKER PANDEY
17 Dec 2018
Director appointed
SADHANA PANDEY (Director)
Director appointed
PALLAVI RANIGA (Director)
15 Feb 2013
Director ceased
PRAMOD SHANKER PANDEY
09 Aug 2012
Charge created
Biotechnology Industry Research Assistance Council - 1.58 cr
18 Dec 2009
Charge created
Department Of Biotechnology - 48.47 Lakh
17 Nov 2009
Charge created
State Bank Of India - 4.00 Lakh
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
All 3 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2020 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Bentec Organo Clays Private Limited U24220MH1988PTC049575 Mumbai, Maharashtra, India
Magnum Chemi-Gran Private Limited U24230TG2005PTC046533 Hyderabad, Telangana, India
Sunbel Alloys Company Of India Limited U27100MH1971PLC015004 Navi Mumbai, Maharashtra, India
Dr. Palep'S Medical Research Foundation Private Limited U24233MH2012PTC235052 Mumbai, Maharashtra, India
Aditya Medi Pharma Private Limited U24240TG2014PTC093149 Hyderabad, Telangana, India
Zenmak Nutrigencies And Health Private Limited U51909TN2017PTC117326 Chennai, Tamil Nadu, India
B&E Diagnostics India Private Limited U74900GJ2015FTC168169 Sanand, Gujarat, India
Bondbay Pharmaceuticals U24232TG2007PTC055590 Quthubullapur Hyderabad, Telangana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Varuna Biocell Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Varuna Biocell Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 50/100, margin trends, ownership structure and peer set for Varuna Biocell Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Varuna Biocell Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Varuna Biocell Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Varuna Biocell Private Limited an active company?

Varuna Biocell Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Varuna Biocell Private Limited financially healthy?

Varuna Biocell Private Limited has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Varuna Biocell Private Limited?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Varuna Biocell Private Limited?

Promoters hold a majority stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Varuna Biocell Private Limited have loans or charges against its assets?

No open charges - all 3 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Varuna Biocell Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Varuna Biocell Private Limited?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.